Ryan Specialty Holdings Inc. $RYAN Shares Sold by Sumitomo Mitsui Trust Group Inc.

Sumitomo Mitsui Trust Group Inc. reduced its stake in Ryan Specialty Holdings Inc. (NYSE:RYANFree Report) by 8.1% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 1,277,042 shares of the company’s stock after selling 112,887 shares during the quarter. Sumitomo Mitsui Trust Group Inc.’s holdings in Ryan Specialty were worth $43,087,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of RYAN. Los Angeles Capital Management LLC purchased a new position in Ryan Specialty in the 4th quarter valued at $25,000. Advisory Services Network LLC purchased a new position in Ryan Specialty during the 3rd quarter worth $28,000. SBI Securities Co. Ltd. lifted its stake in shares of Ryan Specialty by 6,322.2% in the 4th quarter. SBI Securities Co. Ltd. now owns 578 shares of the company’s stock worth $30,000 after acquiring an additional 569 shares during the period. Caitong International Asset Management Co. Ltd increased its stake in shares of Ryan Specialty by 173.7% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 709 shares of the company’s stock worth $37,000 after acquiring an additional 450 shares during the period. Finally, Quarry LP purchased a new position in Ryan Specialty during the third quarter worth about $37,000. Institutional investors and hedge funds own 84.82% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have issued reports on the company. Citigroup dropped their target price on Ryan Specialty from $55.00 to $50.00 and set a “buy” rating on the stock in a research report on Monday, May 4th. Wolfe Research lowered Ryan Specialty from an “outperform” rating to a “peer perform” rating in a report on Thursday. Zacks Research upgraded Ryan Specialty from a “strong sell” rating to a “hold” rating in a research report on Tuesday, June 30th. UBS Group reduced their target price on Ryan Specialty from $52.00 to $50.00 and set a “buy” rating for the company in a report on Wednesday, July 8th. Finally, Barclays boosted their target price on shares of Ryan Specialty from $39.00 to $46.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 7th. Eight equities research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $48.59.

Read Our Latest Report on RYAN

Key Headlines Impacting Ryan Specialty

Here are the key news stories impacting Ryan Specialty this week:

Insider Transactions at Ryan Specialty

In other news, Chairman Patrick G. Ryan bought 120,000 shares of the firm’s stock in a transaction that occurred on Friday, June 5th. The shares were purchased at an average price of $32.50 per share, for a total transaction of $3,900,000.00. Following the completion of the transaction, the chairman owned 13,817,859 shares in the company, valued at $449,080,417.50. The trade was a 0.88% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director John W. Rogers, Jr. bought 7,500 shares of the firm’s stock in a transaction that occurred on Wednesday, June 10th. The shares were purchased at an average price of $35.16 per share, for a total transaction of $263,700.00. Following the transaction, the director owned 117,933 shares of the company’s stock, valued at $4,146,524.28. The trade was a 6.79% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders bought a total of 130,715 shares of company stock worth $4,263,590 over the last ninety days. 52.03% of the stock is currently owned by corporate insiders.

Ryan Specialty Stock Down 0.0%

Shares of NYSE:RYAN opened at $40.40 on Monday. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 2.90. Ryan Specialty Holdings Inc. has a 52-week low of $29.28 and a 52-week high of $67.69. The stock’s fifty day simple moving average is $34.64 and its 200-day simple moving average is $39.31. The company has a market capitalization of $10.65 billion, a P/E ratio of 52.46, a P/E/G ratio of 0.97 and a beta of 0.61.

Ryan Specialty (NYSE:RYANGet Free Report) last posted its quarterly earnings data on Thursday, April 30th. The company reported $0.47 EPS for the quarter, topping analysts’ consensus estimates of $0.43 by $0.04. Ryan Specialty had a return on equity of 41.33% and a net margin of 8.21%.The firm had revenue of $795.23 million during the quarter, compared to analysts’ expectations of $781.44 million. During the same quarter last year, the business posted $0.39 EPS. The firm’s quarterly revenue was up 15.2% compared to the same quarter last year. As a group, equities research analysts forecast that Ryan Specialty Holdings Inc. will post 2.05 earnings per share for the current fiscal year.

Ryan Specialty Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, May 26th. Shareholders of record on Tuesday, May 12th were paid a dividend of $0.13 per share. This represents a $0.52 annualized dividend and a dividend yield of 1.3%. The ex-dividend date of this dividend was Tuesday, May 12th. Ryan Specialty’s dividend payout ratio (DPR) is currently 67.53%.

Ryan Specialty announced that its Board of Directors has approved a share buyback plan on Tuesday, May 26th that allows the company to repurchase $300.00 million in shares. This repurchase authorization allows the company to buy up to 3.5% of its shares through open market purchases. Shares repurchase plans are usually an indication that the company’s leadership believes its shares are undervalued.

Ryan Specialty Profile

(Free Report)

Ryan Specialty Group, Inc (NYSE: RYAN) is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients’ unique needs.

Ryan Specialty’s core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.

Featured Articles

Want to see what other hedge funds are holding RYAN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ryan Specialty Holdings Inc. (NYSE:RYANFree Report).

Institutional Ownership by Quarter for Ryan Specialty (NYSE:RYAN)

Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.